Tibet Cheezheng Tibetan Medicine Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 41.25%

Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has an Asset Resilience Ratio of 41.25% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Tibet Cheezheng Tibetan Medicine Co Ltd (002287) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥2.74 Billion
≈ $400.72 Million USD Cash + Short-term Investments

Total Assets

CN¥6.64 Billion
≈ $971.40 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Tibet Cheezheng Tibetan Medicine Co Ltd's Asset Resilience Ratio has changed over time. See 002287 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Tibet Cheezheng Tibetan Medicine Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002287 stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥2.74 Billion 41.25%
Total Liquid Assets CN¥2.74 Billion 41.25%

Asset Resilience Insights

  • Very High Liquidity: Tibet Cheezheng Tibetan Medicine Co Ltd maintains exceptional liquid asset reserves at 41.25% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Tibet Cheezheng Tibetan Medicine Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tibet Cheezheng Tibetan Medicine Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Fortress Biotech Inc
NASDAQ:FBIO
Biotechnology 11.59%
Summit Therapeutics PLC
NASDAQ:SMMT
Biotechnology 0.00%
Tubize-Fin
BR:TUB
Biotechnology 0.05%
Apellis Pharmaceuticals Inc
NASDAQ:APLS
Biotechnology 0.58%
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
Biotechnology 8.08%
BrightGene Bio Medical Technology C
SHG:688166
Biotechnology 1.00%
BioArctic AB (publ)
ST:BIOA-B
Biotechnology 72.35%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%

Annual Asset Resilience Ratio for Tibet Cheezheng Tibetan Medicine Co Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Tibet Cheezheng Tibetan Medicine Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 41.34% CN¥2.81 Billion
≈ $410.80 Million
CN¥6.79 Billion
≈ $993.65 Million
+10.18pp
2023-12-31 31.17% CN¥1.96 Billion
≈ $287.26 Million
CN¥6.30 Billion
≈ $921.67 Million
+5.02pp
2022-12-31 26.15% CN¥1.54 Billion
≈ $225.25 Million
CN¥5.89 Billion
≈ $861.40 Million
+4.88pp
2021-12-31 21.26% CN¥1.18 Billion
≈ $173.25 Million
CN¥5.57 Billion
≈ $814.74 Million
+20.18pp
2019-12-31 1.08% CN¥32.28 Million
≈ $4.72 Million
CN¥2.98 Billion
≈ $436.67 Million
-17.94pp
2018-12-31 19.02% CN¥440.00 Million
≈ $64.39 Million
CN¥2.31 Billion
≈ $338.43 Million
+0.69pp
2017-12-31 18.33% CN¥421.00 Million
≈ $61.61 Million
CN¥2.30 Billion
≈ $336.06 Million
+8.70pp
2016-12-31 9.64% CN¥200.00 Million
≈ $29.27 Million
CN¥2.08 Billion
≈ $303.74 Million
-3.41pp
2015-12-31 13.04% CN¥270.00 Million
≈ $39.51 Million
CN¥2.07 Billion
≈ $302.93 Million
-5.76pp
2014-12-31 18.81% CN¥337.00 Million
≈ $49.31 Million
CN¥1.79 Billion
≈ $262.21 Million
--
pp = percentage points

About Tibet Cheezheng Tibetan Medicine Co Ltd

SHE:002287 China Biotechnology
Market Cap
$1.90 Billion
CN¥13.01 Billion CNY
Market Cap Rank
#6455 Global
#1459 in China
Share Price
CN¥22.74
Change (1 day)
-0.26%
52-Week Range
CN¥21.90 - CN¥35.78
All Time High
CN¥1299.72
About

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral tibetan medicines, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculo… Read more